Cash and Short Term Investments (Quarterly) Chart

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2004. Start Trial.
Date Value
June 30, 2026 25.42M
March 31, 2026 27.33M
December 31, 2025 30.81M
September 30, 2025 32.56M
June 30, 2025 34.26M
March 31, 2025 36.57M
December 31, 2024 40.36M
September 30, 2024 42.28M
June 30, 2024 44.34M
March 31, 2024 47.14M
December 31, 2023 51.00M
September 30, 2023 51.51M
June 30, 2023 52.88M
March 31, 2023 55.26M
December 31, 2022 58.49M
September 30, 2022 52.51M
June 30, 2022 65.23M
March 31, 2022 67.70M
December 31, 2021 71.43M
September 30, 2021 75.03M
June 30, 2021 77.79M
March 31, 2021 76.30M
December 31, 2020 60.04M
September 30, 2020 61.66M
June 30, 2020 60.44M
Date Value
March 31, 2020 61.33M
December 31, 2019 63.79M
September 30, 2019 62.87M
June 30, 2019 61.74M
March 31, 2019 63.21M
December 31, 2018 62.31M
September 30, 2018 62.44M
June 30, 2018 64.16M
March 31, 2018 62.94M
December 31, 2017 27.99M
September 30, 2017 24.54M
June 30, 2017 22.89M
March 31, 2017 21.64M
December 31, 2016 24.12M
September 30, 2016 24.97M
June 30, 2016 26.57M
March 31, 2016 27.62M
December 31, 2015 22.08M
September 30, 2015 23.61M
June 30, 2015 8.581M
March 31, 2015 9.073M
December 31, 2014 11.67M
September 30, 2014 11.94M
June 30, 2014 13.50M
March 31, 2014 14.78M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Ironwood Pharmaceuticals, Inc. 79.13M
Viking Therapeutics, Inc. 501.66M
IDEAYA Biosciences, Inc. 828.96M
ACADIA Pharmaceuticals, Inc. 956.47M
Alnylam Pharmaceuticals, Inc. 3.308B